Godrej Agrovet Limited announced the launch of TAKAI, a new insecticide specifically developed for rice crops on February 7, 2026. The product launch was disclosed under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Product Overview and Technology

TAKAI is powered by Cyclapryn technology developed by ISK Japan and is designed to combat key rice pests, particularly Stem Borer and Leaf Folder. The insecticide provides comprehensive protection when applied at specific growth stages of the rice crop.

Application Protocol and Effectiveness

TAKAI follows a strategic two-stage application protocol designed to maximize crop protection during critical growth periods. The insecticide should be applied at a dose of 160 ml during 15-30 Days After Transplant (DAT) and again at 40-60 DAT, providing an extensive protection window for the rice crop.

The timing addresses specific pest behavior patterns. During the early vegetative stage (15-30 DAT), Stem Borer damages plants in ways that are difficult for farmers to detect early. Later, during the reproductive stage (40-60 DAT), both Stem Borer and Leaf Folder attack the plant, with Leaf Folder feeding on leaf tissue by folding leaves, thereby reducing the plant's photosynthetic area and crop growth.

Market Impact and Expansion Plans

The company is currently in the process of obtaining label approval for TAKAI in additional crops including Maize, Chilli, Cabbage, Soybean, Chickpea and Sugarcane. This expansion would significantly broaden the product's market reach beyond rice cultivation.

Industry Context and Farmer Requirements

According to N.K. Rajavelu, CEO – Crop Protection Business, Godrej Agrovet, the company's pre-launch rice farmer survey revealed that 77% of farmers value quick pest control, long-lasting effects, and improved crop health. TAKAI addresses these requirements through rapid feeding cessation and sustained pest control over extended periods.

The launch comes at a critical time for Indian agriculture, as rice is grown as a multi-season crop – Kharif, Rabi and Summer – in warm, humid and waterlogged conditions that make crops ideal targets for pest attacks throughout the year. While India is the world's largest producer of rice with production of 150.18 million tonnes, its per-hectare yield remains significantly low at approximately 2.90 tonnes/hectare compared to the global best of 5.00 tonnes/hectare.

Strategic Partnership and Market Position

The collaboration with ISK Japan for Cyclapryn technology represents Godrej Agrovet's strategy of leveraging international research expertise to strengthen its portfolio across key crops. Sunil Kataria, MD & CEO, Godrej Agrovet, emphasized that effective pest management determines the success of Indian rice farmers, and TAKAI enables farmers to protect their crops while improving overall crop health through solutions that offer quick control and longer-duration effectiveness.

Godrej Agrovet Limited has formally responded to the Bombay Stock Exchange (BSE) regarding an inquiry about significant increase in trading volume of its securities across exchanges.

BSE Inquiry and Company Response

The BSE had raised a query on February 3, 2026, seeking clarification about the notable surge in trading volumes of Godrej Agrovet's shares. In response, the company issued a comprehensive statement addressing the exchange's concerns.

Compliance Confirmation

The company emphasized its commitment to transparency and regulatory compliance. Godrej Agrovet confirmed that it maintains strict adherence to disclosure requirements under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Key compliance confirmations include:

• Full compliance with SEBI listing regulations
• No undisclosed developments requiring mandatory disclosure
• Adherence to insider trading regulations
• Prompt dissemination of price-sensitive information

Management Statement

Vivek Raizada, Head – Legal & Company Secretary & Compliance Officer, signed the response on behalf of the company. The statement reaffirmed the company's position as a responsible corporate citizen committed to fulfilling all regulatory obligations.

The company assured that it would continue to make appropriate disclosures as mandated under applicable regulations whenever required, maintaining its track record of transparent communication with stakeholders and regulatory authorities.